BINDII-CLOVER KILLER

Main information

  • Trade name:
  • AMGROW BINDII-CLOVER KILLER
  • Pharmaceutical form:
  • Soluble
  • Units in package:
  • 250mL, 500mL
  • Class:
  • AgChem
  • Medicine domain:
  • Equipment
  • Medicine type:
  • Agrochemical

Documents

Localization

  • Available in:
  • AMGROW BINDII-CLOVER KILLER
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • BLUE COUCH LAWN OR TURF | CARPET GRASS LAWN OR TURF | CENTIPEDE GRASS LAWN OR TURF | COMMON COUCH LAWN OR TURF | FESCUE LAWN OR
  • Therapeutic area:
  • Group I Herbicide
  • Therapeutic indications:
  • BINDY-EYE | CHICKWEED | CLOVER | CREEPING OXALIS | CUDWEED | DANDELION - TARAXACUM OFFICINALE | DOCK | FLEABANE | RIBWORT, RIBGRASS OR LAMB'S TONGUE | BINDII | BOGAN FLEA | BROADLEAF DOCK | CALOTIS HISPIDULA | CLOVER SORREL | COMMON CHICKWEED | COMMON DANDELION | COMMON PLANTAIN | CURLED DOCK | ENGLISH DANDELION | EUROPEAN DANDELION | JO-JO | NARROW LEAF PLANTAIN | ONEHUNGA WEED | RUMEX BROWNII | RUMEX CRISPUS | RUMEX OBTUSIFOLIUS | SMALL-LEAVED OXALIS | STAR BURR | TARAXACUM SPP. | TRUE DANDELION | WOOD SORREL (YELLOW) | YELLOW WOOD SORREL
  • Product summary:
  • Selective herbicide for use on lawns and turf in the home garden.DO NOT apply to Lippia, Strawberry clover, Buffalo or Saltene (Paspalum notatum) lawns. DO NOT feed treated grass clippings to livestock or poultry.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 31506/50783
  • Authorization date:
  • 23-09-2010
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Info

pest

Verified

10-9-2018

Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA

Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA

OTTAWA –Health Canada is sharing the results of its review of potential long-term health effects involving valsartan drugs that were found to contain the impurity N-nitrosodimethylamine (NDMA). Health Canada scientists have assessed the available data to determine the potential increased risk of developing cancer, to help put the risk into context for Canadians.

Health Canada

9-8-2018

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)

As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level. This recall of multiple batches of Valsartan Tablets was prompted due to the detection of trace amounts of N-Nitrosodimethylamine (NDMA), a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer).

FDA - U.S. Food and Drug Administration

13-7-2018

Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

Prinston Pharmaceutical Inc. dba Solco Healthcare LLC. is recalling all lots of Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg to the retail level. This product recall is due to the detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA), made by the manufacturer – Zhejiang Huahai Pharmaceutical Co. Ltd. -- that is used in the manufacture of the subject product ...

FDA - U.S. Food and Drug Administration

9-7-2018

Several drugs containing valsartan being recalled due to contamination with a potential carcinogen

Several drugs containing valsartan being recalled due to contamination with a potential carcinogen

Several drugs containing the ingredient valsartan are being recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), was found in the valsartan used in these products. The valsartan was supplied by Zhejiang Huahai Pharmaceuticals. NDMA is a potential human carcinogen, which means that it could cause cancer with long-term exposure. Five companies have affected products, which are being recalled (identified in table below).

Health Canada

19-10-2018

Today is #NationalMammographyDay! Celebrate and find a certified mammography facility to schedule your next mammogram:  http://www.fda.gov/findmammography pic.twitter.com/1CfTZ735j0

Today is #NationalMammographyDay! Celebrate and find a certified mammography facility to schedule your next mammogram: http://www.fda.gov/findmammography pic.twitter.com/1CfTZ735j0

Today is #NationalMammographyDay! Celebrate and find a certified mammography facility to schedule your next mammogram: http://www.fda.gov/findmammography  pic.twitter.com/1CfTZ735j0

FDA - U.S. Food and Drug Administration

29-6-2018

High doses of MDMA can lead to a spike in body temperature that can result in heart failure or even death.  https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly …
#DrugFacts #FridayFactspic.twitter.com/tPDHYkvW43

High doses of MDMA can lead to a spike in body temperature that can result in heart failure or even death. https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly … #DrugFacts #FridayFactspic.twitter.com/tPDHYkvW43

High doses of MDMA can lead to a spike in body temperature that can result in heart failure or even death. https://www.drugabuse.gov/publications/drugfacts/mdma-ecstasymolly … #DrugFacts #FridayFacts pic.twitter.com/tPDHYkvW43

FDA - U.S. Food and Drug Administration